Robert S. Epstein, M.D., M.S.
DirectoratFate Therapeutics· In proxies 2023–2025
Robert S. Epstein, M.D., M.S. sits on 11 public boards.
Boards2
- Fate TherapeuticsDirector · 11 yr on the boardIndependentPresident, Chief Executive Officer, and Director—Paid as an executive
- IlluminaDirector · 11 yr on the boardIndependentCompensation—Paid as an executive
'%3e%3cg%20id='Clip-2'%3e%3c/g%3e%3cpolyline%20id='Fill-1'%20class='st0'%20points='0.1,56.1%200.2,148.5%2017.7,148.5%2017.7,56.1%200.1,56.1%20'/%3e%3cpolyline%20id='Fill-3'%20class='st1'%20points='46.9,0.9%2046.9,148.5%2064.6,148.5%2064.6,0.9%2046.9,0.9%20'/%3e%3cpolygon%20id='Fill-4'%20class='st1'%20points='94.7,148.5%20112.4,148.5%20112.4,0.9%2094.7,0.9%20'/%3e%3cpath%20id='Fill-5'%20class='st1'%20d='M219.3,148.5h-17.6v-14.2h-0.4c-10.9,23.8-64,25.9-64-18.7l-0.1-59.5h17.6v54.6%20c0,17.4,10,23.8,21.1,23.8c14.6,0,25.8-9.4,25.7-30.8V56.1h17.6L219.3,148.5'/%3e%3c/g%3e%3cpath%20id='Fill-7'%20class='st1'%20d='M244.9,56.1h16.4v14.4h0.4c1.8-5.5,13.1-16.8,29.7-16.8c13.7,0,23,5.9,28.9,17.2%20c6.1-11.3,18.2-17.2,29.3-17.2c28.5,0,35.1,20.3,35.2,41v53.9h-17.6V97.1c0-14.1-3-26.9-19.9-26.9c-17,0-23.6,11.5-23.6,27.9v50.5%20H306v-48.4c0-17.6-2.6-30-19.5-30c-12.7,0-24,9.6-24,30.4v48h-17.6V56.1'/%3e%3cpolygon%20id='Fill-8'%20class='st1'%20points='408.6,148.5%20426.2,148.5%20426.2,56.1%20408.6,56.1%20'/%3e%3cpath%20id='Fill-9'%20class='st1'%20d='M452.1,56.1h17.6v14.2h0.4c10.9-23.8,64-25.9,64,18.7v59.5h-17.6V93.9c0-17.4-10-23.8-21.1-23.8%20c-14.6,0-25.8,9.4-25.7,30.8v47.6h-17.6L452.1,56.1'/%3e%3cg%20id='Group-13'%20transform='translate(0.000000,%2012.000000)'%3e%3cg%20id='Clip-11'%3e%3c/g%3e%3cpath%20id='Fill-10'%20class='st1'%20d='M567.6,66.3c6.4-4.9,12.9-10.5,26.3-10.5c15,0,22.1,9.9,22.1,19.5v3.9c-17.6,0-63.8-2.5-63.8,32%20c0,18,14.8,27.7,32,27.7c14,0,24.6-4.5,32.4-16.4h0.4c0,4.7,0.2,9.4,0.6,14.1h15.6c-1.3-10.7-0.8-65-0.8-64%20c0-35.6-51.9-39.2-75.3-17.2L567.6,66.3z%20M616.1,92.1V98c0,12.5-6.8,26.9-26.3,26.9c-12.1,0-19.9-4.5-19.9-15%20C569.8,91.3,600.3,92.1,616.1,92.1L616.1,92.1z'/%3e%3cpath%20id='Fill-12'%20class='st0'%20d='M11.8,0C5.3,0,0,5.3,0,11.8s5.3,11.8,11.8,11.8s11.8-5.3,11.8-11.8S18.3,0,11.8,0'/%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
Board seats come from each company's latest proxy statement.
Experience
- Fate TherapeuticsPublic company · 1 yr
- Director2025 – Present · 1 yrStock in role +31%
- VeracytePublic company · 3 yr
- Chair of the Board2023 – Present · 3 yrNo stock prices for these years
- IlluminaPublic company · 3 yr
- Director2023 – Present · 3 yrNo stock prices for these years
- PinkDx, Inc.Public company · 2 yr
- Director2024 – Present · 2 yrNo stock prices for these years
- Tasso, Inc.Public company · 3 yr
- Director2023 – Present · 3 yrNo stock prices for these years
- Fate Therapeutics, Inc.Public company
- Director? – PresentNo stock prices for these years
- Decipher BiosciencesPublic company · 2 yr
- Director2019 – 2021 · 2 yrNo stock prices for these years
- Managing Directors, BiologicsPublic company · 3 yr
- Director2017 – 2020 · 3 yrNo stock prices for these years
- Proteus Digital HealthPublic company · 7 yr
- Director2013 – 2020 · 7 yrNo stock prices for these years
- Aveo Pharmaceuticals, Inc.Public company · 2 yr
- Director2012 – 2014 · 2 yrNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?